Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effects of UHMK1 on liver cancer cells

ABSTRACT: Effects of UHMK1 on liver cancer cells

PROVIDER: PRJNA498281 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Effects of UHMK1 on liver cancer cells

Project description:The impact of the kinase UHMK1 on liver cancer cells is unknown. In order to identify UHMK1-dependent genes, UHMK1 was inhibited by siRNA in comparison to nonsense-siRNA-transfected cells.

2019-06-18 | GSE121733 | GEO

SMARCB1 knockdown in liver cancer cells

Project description:SMARCB1 knockdown in liver cancer cells

| PRJNA419313 | ENA

ChIP-seq in liver cancer HepG2 cells

Project description:ChIP-seq in liver cancer HepG2 cells

| PRJNA542691 | ENA

Omics-characterization of tebufenpyrad effects on liver cells

Project description:The biological effects of the pesticide and complex I inhibitor tebufenpyrad (TEBU) on liver cells were investigated by proteomic approaches. Cellular contents were analyzed in dose-response experiments on differentiated HepaRG cell line. Moreover, kinetics were also investigated on HepaRG cells.

2022-10-06 | PXD030822 | Pride

Transcriptome and proteome analysis reveals the anti-cancer properties of Hypnea musciformis macroalgae extract in liver and intestinal cancer cells

Project description:Hypnea musciformis is a red macroalga that is widely distributed in tropical and subtropical regions. It is known to contain various bioactive compounds, including sulfated polysaccharides, flavonoids, and phlorotannins. Recent studies have investigated the potential anticancer effects of extracts from Hypnea musciformis demonstrating their have cytotoxic effects on various cancer cell lines. The anticancer effects of these extracts are thought to be due to the presence of bioactive compounds, which have been shown to have antitumor and immunomodulatory effects. However, further studies are needed to fully understand the molecular mechanisms that underlie these anticancer effects and to determine their potential as therapeutic agents for cancer treatment. We have performed transcriptome and proteome analysis in liver and colon cancer human cell lines following treatment with Hypnea musciformis macroalgae extracts to characterize its anti-tumor effect in detail at the molecular level and to link transcriptome and proteome responses to the observed phenotypes in vitro. We have identified that treatment with the macroalgae extract triggers p53-mediated response at the transcriptional and protein level in liver cancer cells, in contrast to colon cancer cells in which the effects are associated with metabolic changes. Overall, the available evidence suggests that extracts from Hypnea musciformis have the potential to serve as a source of anticancer agents in liver cancer cells through the activation of a p53-mediated anti-tumor response that is linked to inhibition of cellular proliferation and induction of apoptosis.

2023-08-04 | PXD041686 | Pride

Expression data of tigecycline-treated liver cancer cells

Project description:Expression data of tigecycline-treated liver cancer cells

| PRJNA821687 | ENA

HELLS knockdown or overexpression in liver cancer cells

Project description:HELLS knockdown or overexpression in liver cancer cells

| PRJNA875943 | ENA

Effects of organophosphate flame retardants on Atlantic cod liver cells

Project description:Effects of organophosphate flame retardants on Atlantic cod liver cells

| PRJNA407769 | ENA

Cancer therapy induced effects on mesenchymal stem cells

Project description:Cancer therapy induced effects on mesenchymal stem cells

| PRJNA1041783 | ENA

Myeloid cells stimulate liver metastasis through downregulation of ANGPTL7 in cancer cells

Project description:Investigation of the molecular effects of myeloid cells on cancer cells. Myeloid cells were shown to promote metastatic liver progression but the mechanisms involved is unknown. Here we examined gene expression changes in cancer cells upon myeloid cell depletion.

2014-08-31 | GSE60748 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data